Stockscreener 앱 받기
4.83
9.52%
0.42
시장 영업 전:
4.77
-0.06
-1.24%
전일 마감가:
$4.41
열려 있는:
$4.37
하루 거래량:
10.88M
Relative Volume:
2.43
시가총액:
$1.68B
수익:
$62.90M
순이익/손실:
$-204.63M
주가수익비율:
-8.054
EPS:
-0.5997
순현금흐름:
$-181.78M
1주 성능:
+5.92%
1개월 성능:
+9.52%
6개월 성능:
-1.83%
1년 성능:
+102.94%
1일 변동 폭
$4.12
$4.85
1주일 범위
$4.12
$4.85
52주 변동 폭
$1.57
$9.75
Nuvation Bio Inc Stock (NUVB) Company Profile
명칭
Nuvation Bio Inc
전화
332-208-6102
주소
1500 BROADWAY, NEW YORK
Compare NUVB vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
4.83 | 1.53B | 62.90M | -204.63M | -181.78M | -0.5997 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-24 | 개시 | Truist | Buy |
| 2025-11-19 | 개시 | B. Riley Securities | Buy |
| 2025-09-30 | 개시 | Jefferies | Buy |
| 2025-04-23 | 개시 | Citizens JMP | Mkt Outperform |
| 2024-03-27 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-03-26 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-01-06 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-08-02 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-05-04 | 개시 | H.C. Wainwright | Buy |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2021-04-06 | 개시 | RBC Capital Mkts | Outperform |
| 2021-03-08 | 개시 | BMO Capital Markets | Outperform |
| 2021-03-08 | 개시 | BTIG Research | Buy |
| 2021-03-08 | 개시 | Cowen | Outperform |
| 2021-03-08 | 개시 | Jefferies | Buy |
| 2021-03-08 | 개시 | Wedbush | Outperform |
모두보기
Nuvation Bio Inc 주식(NUVB)의 최신 뉴스
Nuvation Bio to Participate in Upcoming Investor Conferences - Investing News Network
JonesTrading Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Nuvation Bio's CEO and CFO line up four investor webcasts in May - Stock Titan
NUVB Stock Rallies As IBTROZI Drives Surprise Profit - StocksToTrade
Nuvation Bio Inc. 2026 Q1 10-Q Report: Financial Statements, Risk Factors, and Forward-Looking Statements - Minichart
A Quick Look at Today's Ratings for Nuvation Bio(NUVB.US), With a Forecast Between $12 to $20 - Moomoo
Nuvation Bio Inc. (NYSE:NUVB) Q1 2026 Earnings Call Transcript - Insider Monkey
Nuvation Bio Falls Short on Q1 2026: $0.01 EPS vs $0.01 Expected - AlphaStreet
Citizens reiterates Nuvation Bio stock rating on Ibtrozi launch progress By Investing.com - Investing.com Australia
Citizens reiterates Nuvation Bio stock rating on Ibtrozi launch progress - Investing.com
Nuvation Bio Q1 2026 Earnings Call Transcript - MarketBeat
Nuvation Bio Q1 Earnings Call Highlights - Yahoo Finance
Nuvation Bio Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Nuvation Bio Inc. (NUVB) lags Q1 earnings estimates - MSN
NUVB: Ibtrozi's first-line uptake and revenue growth accelerate, supported by strong financials - TradingView
Nuvation Bio (NUVB) Q1 2026 Earnings Transcript - The Globe and Mail
MSN Money - MSN
Earnings call transcript: Nuvation Bio Q1 2026 sees revenue beat, flat EPS - Investing.com
Nuvation Bio Inc. (NUVB) Lags Q1 Earnings Estimates - Yahoo Finance
Nuvation Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Nuvation Bio Q1 Swings to Profit, Revenue Rise - marketscreener.com
Earnings Flash (NUVB) Nuvation Bio Posts Q1 EPS $0.01, vs. FactSet Est of $0.03 Loss - marketscreener.com
Earnings Flash (NUVB) Nuvation Bio Inc. Reports Q1 Revenue $83.2M, Vs. FactSet Est of $65.7M - Moomoo
Nuvation Bio Reports First Quarter 2026 Financial Results and Provides Business Update - PR Newswire
Nuvation Bio (NUVB) swings to Q1 profit on $83M taletrectinib revenue - Stock Titan
Nuvation Bio Inc. (NUVB) reports next week: Wall Street expects earnings growth - MSN
Nuvation Bio earnings up next: Can IBTROZI launch momentum continue? By Investing.com - Investing.com South Africa
Nuvation Bio earnings up next: Can IBTROZI launch momentum continue? - Investing.com UK
Nuvation Bio Inc. (NYSE:NUVB) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Are options traders betting on a big move in Nuvation Bio stock? - MSN
Earnings Preview: Nuvation Bio to Report Financial Results Post-market on May 04 - Moomoo
H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $17 - Moomoo
Nuvation Bio gains global rights to brain cancer therapy from Daiichi Sankyo - MSN
H.C. Wainwright reiterates Nuvation Bio stock rating on NCCN addition - Investing.com UK
H.C. Wainwright reiterates Nuvation Bio stock rating on NCCN addition By Investing.com - Investing.com India
Wall Street Analysts Believe Nuvation Bio (NUVB) Could Rally 25.14%: Here's is How to Trade - MSN
Down 24% in 4 weeks, here's why Nuvation Bio (NUVB) looks ripe for a turnaround - MSN
Nuvation Bio Inc. (NUVB) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib as Recommended Option to Clinical Practice Guidelines in Oncology for Central Nervous System Cancers - Investing News Network
Nuvation Bio announces National Comprehensive Cancer Network® adds taletrectinib (Ibtrozi®) as recommended option - marketscreener.com
Nuvation Bio (NUVB) Projected to Post Earnings on Monday - MarketBeat
Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib (IBTROZI®) as Recommended Option to Clinical Practice Guidelines in Oncology for Central Nervous System Cancers - PR Newswire
Nuvation Bio Inc (NUVB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):